Featured Stock: Gemini Explorations, Inc.
(OTCBB: GXPI | charts | news | PowerRating) Current Price (0.17) www.WallstreetStockReview.com
Gemini Explorations, Inc. Provides Second Payment to Acquire the Los Chorros Gold Mine Wednesday November 7, 2:30 am ET Los Chorros Gold Mine: A Producing Gold Project in Antioquia, Colombia CALGARY, AB----Nov 7, 2007 -- Gemini Explorations, Inc. ("Gemini") (OTC BB:GXPI.OB - News) is pleased to announce that it has executed the second payment of US$40,000 as outlined in the definitive agreement to acquire the Los Chorros Gold Mine, a producing gold property in the El Bagre-Zargoza mining district, department of Antioquia, Colombia. Gemini has acquired an 80 percent majority controlling interest in the property for the sum of U$100,000 and the issuance of 2,500,000 restricted shares of GXPI. The company has paid US$50,000 to date in two separate payments leaving US$50,000 to complete the acquisition. Gemini has first right of refusal to acquire the remaining 20 % interest in the mine within 18 months of the Effective Date.
The Los Chorros Mine is currently being mined with extremely antiquated equipment, and Gemini believes that the project could be turned into a highly efficient producing gold project with low capital costs. Current mining operations at Los Chorros recover a low percentage of the available gold and precious metals present on the property. The plant would initially run at 30 to 50 tonnes/day with a targeted production rate of 100 tonnes per day during the first year. Gemini reported on November 5, 2007 that a 100 tonne per day production rate would produce US$1,080,280 monthly and over US$12,900,000 annually. These estimates are based on US$730 per ounce gold with US$200 per ounce operating and production costs netting US$530 per ounce.
The total cost of the project is estimated to be US$595,900, adding a contingency factor of 30% would bring the maximum projected total to US$774,700.The reports were prepared by general manager Juan Fernando Restrepo and chief geologist Carlos Alberto Vera of Minera Primecap Geological Services (MPGS) of Medellin, Colombia.
Historically one of the largest gold producing countries in the world, Colombia's vast mineral potential has remained virtually unexplored using modern exploration and mining techniques. The Department (Province/State) of Antioquia alone produces over 1,000,000 ounces of gold per year currently, and most of it is produced from antiquated production equipment and facilities. Driven by a new era of political and economic stability and an investment-friendly mining code, Colombia has emerged as one of the resource sector's most attractive new mining frontiers.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the expectation of the gold production of the property to be acquired, the low capital costs to upgrade the Los Chorros operating plant, the assumed production and net cash flow.Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with mineral exploration. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the 2006 fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
Contact: Contact: Michael Hill President Gemini Explorations, Inc.
Suite 103, 240-11th Ave SW Calgary, AB T2R 0C3
http://www.geminiexploration.com email: info@geminiexploration.com
IR info: 1 877 700 1644
Source: Gemini Explorations, Inc.
For an in-depth analyst report, please visit: www.WallstreetStockReview.com
Credence Systems (NasdaqGS:CMOS) Current Price (2.50) www.WallstreetStockReview.com MILPITAS, CA--Nov 6, 2007 -- Credence Systems (NasdaqGS:CMOS - News), a leading provider of test and analytical solutions from design to production for the worldwide semiconductor industry, today announced major additions to its comprehensive range of integrated analytical tools designed to meet the complex challenges facing manufacturers of today's advanced 65nm, 45nm and beyond device technologies. The expanded product portfolio -- including the Ruby(TM) laser voltage probing system, the OptiFIB-IV focused ion-beam (FIB) system, and the significantly enhanced Meridian(TM) and TriVision(TM) electrical failure analysis platforms -- will be showcased at the 33rd annual International Symposium for Testing and Failure Analysis (ISTFA 2007, Booth#425) to be held November 4-7 at the McEnery Convention Center, San Jose, California. Credence Systems Corporation is a leading provider of debug, characterization & ATE solutions for the global semiconductor industry. With a commitment to applying innovative technology to lower the cost-of-test, Credence delivers competitive cost & performance advantages to integrated device manufacturers (IDMs), wafer foundries, outsource assembly & test (OSAT) suppliers & fabless chip companies worldwide. A global, ISO 9001-certified company with a presence in 20 countries, Credence is headquartered in Milpitas, California. More information is available at http://www.credence.com.
Advanced Cell Technology, Inc.
(OTC BB:ACTC) Current Price (0.28) www.WallstreetStockReview.com ORLANDO, Fla.--Nov. 7--Advanced Cell Technology, Inc. (OTCBB: ACTC - News) today announced that a controlled, randomized clinical trial led by Catholic Healthcare West's Dr. Nabil Dib, M.D., M.Sc., F.A.C.C., using ACT's myoblast therapy demonstrated marked improvement in heart failure symptoms after both six and twelve months. The trial also showed evidence that the hearts of the patients that received the therapy showed less cardiac remodeling (an increase in the size of the heart that signifies worsening of function) than did control patients. Dr. Dib presented the results of the trial today in a Late Breaking Clinical Trial Session at the American Heart Association's annual meeting in Orlando, Florida. Advanced Cell Technology, Inc. is a biotechnology company applying embryonic stem cell technology in the emerging field of regenerative medicine. The company operates facilities in Alameda, California and Worcester, Massachusetts.
GTx, Inc.
(NasdaqGM:GTXI) Current Price (16.35) www.WallstreetStockReview.com MEMPHIS, Tenn.--Nov. 6--GTx, Inc. (NASDAQ: GTXI - News) today reported financial results for the third quarter of 2007. The net loss for the third quarter and nine months ended September 30, 2007, was $10.2 million and $27.6 million, respectively, compared with a net loss of $10.9 million and $30.8 million for the same periods in 2006. At September 30, 2007, GTx had cash and cash equivalents of $90.9 million. GTx, headquartered in Memphis, Tenn., is a biopharmaceutical company dedicated to the discovery, development, and commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis and bone loss, muscle wasting and other serious medical conditions. GTx is developing ACAPODENE (toremifene citrate), a selective estrogen receptor modulator, or SERM, in two separate clinical programs in men: first, a pivotal Phase III clinical trial for the treatment of serious side effects of androgen deprivation therapy for advanced prostate cancer, and second, a pivotal Phase III clinical trial for the prevention of prostate cancer in high risk men with high grade prostatic intraepithelial neoplasia, or PIN. GTx has licensed to Ipsen Limited exclusive rights in Europe to develop and commercialize ACAPODENE. GTx has executed an agreement for a collaboration with Merck & Co., Inc. for the development and global commercialization of selective androgen receptor modulators, or SARMs, a new class of drugs with the potential to treat a variety of indications associated with muscle wasting and bone loss including sarcopenia and osteoporosis, cancer cachexia, and chronic kidney disease muscle wasting. GTx is also developing GTx-878, an estrogen receptor beta agonist for the treatment of benign prostatic hyperplasia and chronic prostatitis. GTx is planning to initiate human clinical studies for GTx-878 in 2009.
Turbine Truck Engines, Inc (OTC BB:TTEG) Current Price (.67) www.WallstreetStockReview.com DELAND, FLORIDA--Nov 6, 2007 -- Turbine Truck Engines, Inc. (OTC BB:TTEG.OB - News) announces today an alliance with Embry-Riddle Aeronautical University (Daytona, Florida campus) with the objective of further development of the (US Patented) 'Detonation Cycle Gas Turbine Engine' technology for manufacturing heavy-duty highway trucks. Turbine Truck Engines, Inc., a development stage company, owns an exclusive license for manufacturing and marketing heavy-duty highway truck engines in the United States. The company has license for utilizing Alpha Engines Corporation's 'Detonation Cycle Gas Turbine Engine' technology for manufacturing heavy-duty highway trucks. The company was founded in 2000 and is headquartered in Deland, Florida.
WallStreetStockReview.com is owned and operated by Iron Consulting.
Verify all claims and do your own due diligence. Iron Consulting profiles are not a solicitation or recommendation to buy, sell or hold securities. Iron Consulting is not offering secu rities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Iron Consulting is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b),WallStreetStockReview.com is owned and operated by Iron Consulting. Iron Consulting www.ironconsultinginc.com has receive seventy two thousand dollars in 2006 and thirty six thousand in 2007 from Equity Alliance Intl. www.equityallianceir.com for a internet marketing program. Neither Iron Consulting nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Iron Consulting receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Iron Consulting statements and opinions and such statements and opinions cannot be considered independent. Iron Consulting and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements ar e made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Iron Consulting services are often paid for using free-trading shares. Iron Consulting may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.
CONTACT: WallStreetStockReview.com e-mail: ironconsulting@gmail.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
|
|
